Unitika (3103) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
14 Aug, 2026Executive summary
Revenue for Q1 FY2027 was ¥24,108 million, a 22.0% decrease year-over-year due to business withdrawals.
Operating profit rose 46.4% year-over-year to ¥4,162 million, driven by high-value product sales, price revisions, and cost reductions.
Ordinary profit increased 135.7% year-over-year to ¥4,322 million, aided by foreign exchange gains and reduced interest expenses.
Net income attributable to shareholders surged 211.3% year-over-year to ¥4,056 million.
Financial highlights
Gross profit for Q1 FY2027 was ¥7,826 million, up from ¥7,673 million year-over-year.
Comprehensive income for Q1 FY2027 was ¥3,870 million, up 185.2% year-over-year.
EPS for Q1 FY2027 was ¥70.35, compared to ¥22.60 in the prior year.
Total assets at quarter-end were ¥148,775 million, down ¥1,929 million from the previous fiscal year-end.
Net assets increased by ¥3,607 million to ¥57,652 million.
Outlook and guidance
Full-year FY2027 revenue forecast is ¥84,000 million, a 29.2% decrease year-over-year.
Operating profit forecast is ¥8,000 million (down 24.2%), ordinary profit ¥6,500 million (down 37.5%), and net income ¥5,000 million (down 72.5%).
No change to previously announced full-year guidance.
Latest events from Unitika
- Operating profit soared 80.3% year-over-year despite a 6.2% revenue decline.3103
Q4 2026 - Profit and margins surged on restructuring and asset sales, with a strong outlook for earnings.3103
Q3 2026 - Operating profit surged on cost cuts and restructuring, but special losses led to a net loss.3103
Q2 2026 - Operating profit returned to positive, but a major impairment loss drove a significant net loss.3103
Q2 2025 - Strong profit recovery and higher sales, with Q2 outlook raised amid persistent cost risks.3103
Q1 2025 - Operating profit rebounded, but restructuring costs drove a large net loss and no dividend was paid.3103
Q4 2025 - Sales and operating profit rebounded, but a major impairment loss drove a steep net loss.3103
Q3 2025